Table 2 Physicochemical and in vitro pharmacokinetic properties of 7.44.

From: Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects

No

Description

Value

1

Kinetic solubility (99% PBS, 1% DMSO)

177 ± 8 µM

2

Plasma protein binding (mouse plasma, 60 min)

98.4 ± 0.2%

3

Plasma stability (mouse plasma, 0–240 min)

No degradation

4

Hepatocyte stability (mouse hepatocytes)

2.5 µl/min/million cells

5

Chemical stability in PBS (0–4 h)

No degradation

6

Cytochrome P450 inhibition (at 1 µM and 10 µM concentration)

See Fig. 7